Antiviral Medications for Treatment of Nonsevere Influenza: A Systematic Review and Network Meta-Analysis

医学 抗病毒治疗 病毒学 重症监护医学 病毒 慢性肝炎
作者
Ya Gao,Yunli Zhao,Ming Liu,Shuyue Luo,Yamin Chen,Xiaoyan Chen,Qingyong Zheng,Jianguo Xu,Yanjiao Shen,Wanyu Zhao,Zhifan Li,Sha Huang,Jie Huang,Jinhui Tian,Gordon Henry Guyatt,Qiukui Hao
出处
期刊:JAMA Internal Medicine [American Medical Association]
卷期号:185 (3): 293-293 被引量:61
标识
DOI:10.1001/jamainternmed.2024.7193
摘要

Importance The optimal antiviral drug for treatment of nonsevere influenza remains unclear. Objective To compare effects of antiviral drugs for treating nonsevere influenza. Data Sources MEDLINE, Embase, CENTRAL, CINAHL, Global Health, Epistemonikos, and ClinicalTrials.gov were searched from database inception to September 20, 2023. Study Selection Randomized clinical trials comparing direct-acting influenza antiviral drugs to placebo, standard care, or another antiviral drug for treating people with nonsevere influenza. Data Extraction and Synthesis Paired reviewers independently performed data extraction and risk of bias assessment. A frequentist network meta-analysis was performed to summarize the evidence and the certainty of evidence was evaluated using the GRADE approach. Main Outcomes and Measures Mortality, admission to hospital, admission to the intensive care unit, duration of hospitalization, time to alleviation of symptoms, emergence of resistance, and adverse events. Results Overall, 73 trials with 34 332 participants proved eligible. Compared with standard care or placebo, all antiviral drugs had little or no effect on mortality for low-risk patients and high-risk patients (all high certainty). All antiviral drugs (no data for peramivir and amantadine) had little or no effect on hospital admission for low-risk patients (high certainty). For hospital admission in high-risk patients, oseltamivir (risk difference [RD], −0.4%; 95% CI, −1.0 to 0.4; high certainty) had little or no effect and baloxavir may have reduced risk (RD, −1.6%; 95% CI, −2.0 to 0.4; low certainty); all other drugs may have had little or uncertain effect. For time to alleviation of symptoms, baloxavir probably reduced symptom duration (mean difference [MD], −1.02 days; 95% CI, −1.41 to −0.63; moderate certainty); umifenovir may have reduced symptom duration (MD, −1.10 days; 95% CI, −1.57 to −0.63; low certainty); oseltamivir probably had no important effect (MD, −0.75 days; 95% CI, −0.93 to −0.57; moderate certainty). For adverse events related to treatment, baloxavir (RD, −3.2%; 95% CI, −5.2 to −0.6; high certainty) had few or no adverse events; oseltamivir (RD, 2.8%; 95% CI, 1.2 to 4.8; moderate certainty) probably increased adverse events. Conclusions and Relevance This systematic review and meta-analysis found that baloxavir probably reduced risk of hospital admission for high-risk patients and may reduce time to alleviation of symptoms, without increasing adverse events related to treatment in patients with nonsevere influenza. All other antiviral drugs either probably have little or no effect, or uncertain effects on patient-important outcomes.
最长约 10秒,即可获得该文献文件

科研通智能强力驱动
Strongly Powered by AbleSci AI
科研通是完全免费的文献互助平台,具备全网最快的应助速度,最高的求助完成率。 对每一个文献求助,科研通都将尽心尽力,给求助人一个满意的交代。
实时播报
苹果发布了新的文献求助10
1秒前
稀西完成签到,获得积分10
2秒前
2秒前
小田完成签到 ,获得积分10
3秒前
3秒前
甜美的谷云完成签到 ,获得积分10
4秒前
6秒前
冷酷画板完成签到,获得积分20
7秒前
月亮喜欢吃月饼完成签到 ,获得积分10
7秒前
忧郁的汉堡完成签到,获得积分10
7秒前
强小强努力努力完成签到,获得积分10
7秒前
Lyuoah完成签到,获得积分10
7秒前
9秒前
9秒前
稀西发布了新的文献求助10
10秒前
675675发布了新的文献求助30
10秒前
11秒前
Maestro_S的应助被achilles采纳,获得10
11秒前
乐乐的应助被achilles采纳,获得10
11秒前
阿申爱乐的应助被正直迎夏采纳,获得30
12秒前
ccccc完成签到 ,获得积分10
13秒前
科研通AI65的应助被Lighter采纳,获得10
13秒前
科研通AI6.3的应助被小艾同学采纳,获得10
14秒前
yummy完成签到 ,获得积分10
16秒前
16秒前
啦啦啦完成签到,获得积分10
17秒前
19秒前
乌龙茶发布了新的文献求助10
23秒前
molihuakai的应助被fengfengfeng采纳,获得10
23秒前
23秒前
空白格完成签到 ,获得积分10
24秒前
sun完成签到,获得积分10
25秒前
25秒前
yeo发布了新的文献求助10
25秒前
Coco完成签到,获得积分10
26秒前
27秒前
cc发布了新的文献求助20
28秒前
28秒前
28秒前
落叶完成签到,获得积分10
29秒前
高分求助中
(应助此贴封号)【重要!!请各用户(尤其是新用户)详细阅读】【科研通的精品贴汇总】 10000
拉伸高分子熔体中缠结行为的模拟和小角中子散射研究 1700
The World Atlas of Wine 9th edition 1000
奈特基础组织学:配套组织病理学(第4版)(Netter's Essential Histology With Correlated Histopathology) 800
八旗制度の研究 600
Boundaries and Bodhisattvas 500
高分子基功能界面水蒸发材料与应用研究 500
热门求助领域 (近24小时)
化学 材料科学 医学 生物 纳米技术 计算机科学 工程类 有机化学 化学工程 生物化学 物理 复合材料 内科学 催化作用 光电子学 人工智能 细胞生物学 无机化学 物理化学 数学
热门帖子
关注 科研通微信公众号,转发送积分 8181767
求助须知:如何正确求助?哪些是违规求助? 9571480
关于积分的说明 21818225
捐赠科研通 7778030
什么是DOI,文献DOI怎么找? 3433524
关于科研通互助平台的介绍 2557696
邀请新用户注册赠送积分活动 2479598